Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2490 Target Snapshot

5-hydroxytryptamine receptor 2A · SINGLE PROTEIN · Sus scrofa

145Compounds
15Assays
1Approved Drugs
127.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P50129. Use UniProt P50129 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P50129 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats 5-hydroxytryptamine receptor 2A as ChEMBL target CHEMBL2490, mapped to UniProt P50129. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
5-hydroxytryptamine receptor 2A
SINGLE PROTEIN · Sus scrofa
As of 2026-09-14
ChEMBL target ID
CHEMBL2490
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P50129
5-hydroxytryptamine receptor 2A
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether 5-hydroxytryptamine receptor 2A is the right protein anchor across sources, using UniProt P50129 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Label5-hydroxytryptamine receptor 2A
UniProt AccessionP50129
Component TypeProtein
Sequence Length470 aa

5-hydroxytryptamine receptor 2A

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as 5-hydroxytryptamine receptor 2A, mapped to UniProt P50129. Sequence length is 470 aa.

Mapped IDP50129
Review name5-hydroxytryptamine receptor 2A
OrganismSus scrofa
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase III
1
Phase II
Assay Mix

Activity Type Distribution

KI116.0
KD11.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL201170 9.19 Kd 0.6457 Preclinical
CHEMBL203637 9.05 Kd 0.8913 Preclinical
CHEMBL51 8.88 Kd 1.318 Clinical
CHEMBL201525 8.7 Kd 1.995 Preclinical
CHEMBL380330 8.69 Kd 2.042 Preclinical
CHEMBL231070 8.67 Kd 2.138 Preclinical
CHEMBL276778 8.47 Kd 3.388 Preclinical
CHEMBL216439 8.42 Kd 3.802 Preclinical
CHEMBL508399 8.4 Kd 3.981 Preclinical
CHEMBL389357 8.24 Kd 5.754 Preclinical
Distribution

pChEMBL Value Distribution

14
5.0
28
5.5
31
6.0
8
6.5
3
7.0
2
7.5
4
8.0
4
8.5
2
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

HALOPERIDOL
CHEMBL54
Approved 1967
Assay Landscape

Assay Landscape

15
Total Assays
91
Tested Compounds
2
Assay Types
Binding — 14 assays, 91 compounds
BAO Format Assays Compounds Avg pChEMBL
cell membrane format 9 54 5.8
single protein format 3 16 6.3
assay format 1 9 6.0
tissue-based format 1 12 6.0
Functional — 1 assays, 11 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 1 11 8.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine